Aim: To investigate the protective effects of arctigenin (ATG), a phenylpropanoid dibenzylbutyrolactone lignan from Arctium lappa L (Compositae), against ER stress in vitro and the underlying mechanisms. Methods: A cell-based screening assay for ER stress regulators was established. Cell viability was measured using MTT assay. PCR and Western blotting were used to analyze gene and protein expression. Silencing of the CaMKKβ, LKB1, and AMPKα1 genes was achieved by RNA interference (RNAi). An ATP bioluminescent assay kit was employed to measure the intracellular ATP levels. Results: ATG (2.5, 5, and 10 µmol/L) inhibited cell death and unfolded protein response (UPR) in a concentration-dependent manner in cells treated with the ER stress inducer brefeldin A (100 nmol/L). ATG (1, 5, and 10 µmol/L) significantly attenuated protein synthesis in cells through inhibiting mTOR-p70S6K signaling and eEF2 activity, which were partially reversed by silencing AMPKα1 with RNAi. ATG (1-50 µmol/L) reduced intracellular ATP level and activated AMPK through inhibiting complex I-mediated respiration. Pretreatment of cells with the AMPK inhibitor compound C (25 µmol/L) rescued the inhibitory effects of ATG on ER stress. Furthermore, ATG (2.5 and 5 µmol/L) efficiently activated AMPK and reduced the ER stress and cell death induced by palmitate (2 mmol/L) in INS-1 β cells. Conclusion: ATG is an effective ER stress alleviator, which protects cells against ER stress through activating AMPK, thus attenuating protein translation and reducing ER load.
Introduction
The endoplasmic reticulum (ER) is a highly dynamic organelle in which proteins and lipids are synthesized, modified, and transported. Under conditions such as glucose starvation, hypoxia, aberrant Ca 2+ regulation, and virus infection, collectively known as ER stress, proteins fail to be correctly folded and eventually accumulate and aggregate in the ER lumen. In response to the abnormalities in the ER, the ER stress response or the unfolded protein response (UPR) is triggered by three ER-localized transmembrane proteins: PKR-like ER kinase (PERK), activation transcription factor (ATF6), and inositolrequiring kinase (IRE1). During the ER stress response, PERK phosphorylates and inhibits eukaryotic initiation factor 2α (eIF2α), leading to translation attenuation [1] ; ATF6 translocates to the Golgi, where it is sequentially cleaved by the S1P and S2P proteases to form an active 50 kDa transcription factor [2] ; and IRE1 cleaves the mRNA transcript of X box protein 1 (XBP1) by an unconventional splicing mechanism [3] . The activation of these pathways restricts protein load on the ER through transient attenuation of general protein synthesis, promotes degradation of misfolded proteins and increases protein folding capacity in the ER [4] . However, severe or prolonged accumulation of unfolded proteins triggers apoptosis of target cells.
Accumulating evidence suggest that ER stress is implicated in a wide range of diseases, including diabetes, neurodegeneration, stroke, cardiac disease, muscle degeneration and others [5] . Particularly, ER stress has been reported to play a central role in pancreatic β-cell demise in type 2 diabetes and perhaps also in type 1 diabetes [6] . Elevated ER stress markers have been detected in islet tissues of diet-induced and genetic db/db diabetic mice [7] , as well as of type 2 diabetes patients [8] . Thus, we hypothesize that alleviation of ER stress may represent an attractive therapeutic strategy for the treatment of www.nature.com/aps Gu Y et al Acta Pharmacologica Sinica npg β-cell death in type 2 diabetes. Arctigenin (ATG) is a phenylpropanoid dibenzylbutyrolactone lignan from Arctium lappa L (Compositae) [9] . Arctium lappa L, commonly known as burdock, has been widely used in traditional Chinese medicine (TCM) for treating inflammation [10] . It has also been used therapeutically in Europe and North America for hundreds of years [11] . The root of Arctium lappa L, a popular edible vegetable in China and Japan, is used to make a general health tonic. Previous studies have shown that ATG exerted protective effects against oxidation [12] , viral infection [13] , and cancer [14] . Most recently, two research groups have reported that ATG could block the UPR and preferentially inhibit tumor cell viability under glucose-deprived conditions [15, 16] . The molecular targets and mechanisms of ATG however remain unclear.
In the present study, we established a cell-based screening assay for ER stress regulators and identified ATG as a protective agent against ER stress, which efficiently protected HepG2 cells from the ER stress inducer brefeldin A (BFA)-induced cell death, and investigated its action mechanism. We then explored its therapeutic potential in treating diabetes by examining its effects on palmitate-induced β-cell death.
Materials and methods

Reagents and antibodies
Arctigenin (purity >99%), isolated from dried seeds of A. lappa as previously described [17] , was provided by Dr Li-hong HU. Penicillin, streptomycin, Brefeldin A, compound C, 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR), D-glucose, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and propidium iodide (PI) were purchased from Sigma (St Louis, Mo, USA). Palmitate was purchased from Takeda Chemical Industries (TCI, Tokyo, Japan). Fatty acid-free bovine serum albumin (BSA) was purchased from Equitech-Bio (Kerrville, TX, USA). α-MEM medium, RPMI-1640 medium and fetal bovine serum (FBS) were purchased from Invitrogen (Carlsbad, CA, USA). All other chemicals (molecular biology grade) were obtained from standard commercial sources. Anti-PARP antibody, anti-phosphorylated AMPKα (Thr172), anti-phosphorylated acetyl-CoA carboxylase (ACC, Ser79), anti-phosphorylated eIF2α (Ser51), antieIF2α, anti-phosphorylated mTOR (Ser2448), anti-mTOR, antiphosphorylated p70S6K (Thr389), anti-p70S6K, anti-phosphorylated eEF2 (Thr56), anti-eEF2, and anti-GAPDH antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). Anti-AMPKα antibody was purchased from Epitomics (Burlingame, CA, USA).
Cell culture
HepG2 cells, a human hepatocellular liver carcinoma cell line, were grown in α-MEM containing 10% (v/v) FBS, 100 U/mL penicillin and 100 μg/mL streptomycin. INS-1 β-cells, a rat insulinoma cell line, were grown in RPMI-1640 medium supplemented with 10% FBS, 1 mmol/L sodium pyruvate, 2 mmol/L L-glutamine, 10 mmol/L HEPES, 0.05 mmol/L 2-mercaptoethanol, 100 units/mL penicillin and 100 mg/mL streptomycin. All cell lines were cultured at 37 °C in a humidified atmosphere of 95% air and 5% CO 2.
MTT assay and PI staining Cell growth rate was measured by the MTT assay. Briefly, after treatment, 20 μL MTT (5 mg/mL) was added to the culture medium. After incubating for 3 h at 37 °C, the cells were solubilized in dimethyl sulfoxide (DMSO), and the absorbance of each well was measured at 570 nm with a spectrophotometer (Molecular Devices, Silicon Valley, CA, USA). Cell death was examined by PI staining. After treatment, cells were stained with 15 μg/mL PI for 10 min, and then washed with PBS and photographed using a UV microscope.
Western blot analysis Cells were lysed with 1×Laemmli buffer (Sigma, St Louis, MO, USA) containing 2 mmol/L NaF and 2 mmol/L Na 3 VO 4 , which are used to prevent the dephosphorylation of serine/ threonine and tyrosine residues, respectively. Proteins were separated by sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane (Millipore, Bedford, MA, USA). Membrane was blocked in 5% nonfat milk for 1 h at room temperature and then subjected to immunostaining with primary antibodies at 4 °C overnight and peroxidase-conjugated secondary antibodies at room temperature for 1 h. Immunoreactivity was revealed with the Supersignal chemiluminescence dection kit (Pierce, Rockford, IL, USA). Immunoblots were scanned and quantified using the software ImageJ (NIH).
Isolation of total RNA, semiquantitative and quantitative reverse transcription PCR Total RNA was extracted from cells using TRIzol reagent (Invitrogen, Paisley, UK) following the manufacturer's instructions. 4 μg total RNA and ReverTra Ace reverse transcriptase (Toyobo, Osaka, Japan) were used in the reverse transcription reaction.
Taq DNA polymerase (Takara, Tokyo, Japan) was used for the subsequent polymerase chain reaction (PCR). The specific primers for semiquantitative PCR were as follows: 5'-CCTTGTAGTTGAGAACCA-3' (forward) and 5'-GGGCT-TGGTATATATGTGGG-3' (reverse) for both unspliced and spliced XBP-1 (human); 5'-ACCACAGTCCATGCCA-TCAC-3' (forward) and 5'-TCCACCACCCTGTTGCTG-3' (reverse) for GAPDH (human); 5'-TTACGAGAGAAAACT-CATGGGC-3' (forward) and 5'-GGGTCCAACTTGTCCA-GAATGC-3' (reverse) for both unspliced and spliced XBP-1 (rat); 5'-CCCCAATGTATCCGTTGTGGA-3' (forward) and 5'-GCCTGCTTCACCACCTTCTT-3' (reverse) for GAPDH (rat). RT-PCR for XBP-1 was performed for 30 cycles and GAPDH for 20 cycles. PCR products were separated on 8% polyacrylamide gel and visualized by ethidium bromide staining.
Quantitative PCR was performed and analyzed in ABI-PRISM 7700 Sequence Detection System (Applied Biosystems) with SYBR green real-time PCR kit (Takara). The specific primer sequences were as follows: 5'-GGC-CAGTTTGGTGTCGGTTT-3' (forward) and 5'-CGTTC-CCCGTCCTAGAGTGTT-3' (reverse) for Grp94 (human); 5 ' -T G G A C T G C A G G T G C T G A T A G -3 ' ( f o r w a r d ) a n d 5'-GGATTCTTGGTTGCCTGGTA-3' (reverse) for EDEM (human); 5'-TCAAACCTCATGGGTTCTCC-3' (forward) and 5'-GTGTCATCCAACGTGGTCAG-3' (reverse) for ATF4 (human); 5'-TGTGACCTCTGCTGGTTCTG-3' (forward) and 5'-TGGAAGCCTGGTATGAGGAC-3' (reverse) for CHOP (human); 5'-CACGTCCAACCCGGAGAA-3' (forward) and 5'-ATTCCAAGTGCGTCCGATG-3' (reverse) for Grp78 (Rat); 5'-TACTATGCCAGTCAGAAGAAAACG-3' (forward) and 5'-CATCCTTTCTATCCTGTCTCCATA-3' (reverse) for Grp94 (Rat); 5'-GACATGCCGCCTGGAGAAAC-3' (forward) and 5'-AGCCCAGGATGCCCTTTAGT-3' (reverse) for GAPDH (Rat).
RNA interference and transfection
Small interfering RNAs (siRNAs) against Ca 2+ /calmodulindependent protein kinase kinase β (CaMKKβ), liver kinase B1 (LKB1) and AMPKα1 as well as a nonsilencing control siRNA were purchased from GenePhama (Shanghai, China). The siRNA sequences applied to target CaMKKβ were: 5'-CGAUCGUCAUCUCUGGUUAdTdT-3' (sense) and 5'-UAACCAGAGAUGACGAUCGdTdT-3' (antisense); for LKB1, 5'-GGCUCUUACGGCAAGGUGAdTdT-3' (sense) and 5'-UCACCUUGCCGUAAGAGCCdTdT-3' (antisense) and, for AMPKα1, 5'-UGCCUACCAUCUCAUAAUAdTdT-3' (sense) and 5'-UAUUAUGAGAUGGUAGGCAdTdT-3' (antisense) were used. The siRNA sequences employed as a negative control were 5'-UUCUCCGAACGUGUCACGUTT-3' (sense) and 5'-ACGUGACACGUUCGGAGAATT-3' (antisense).
Transfections of HepG2 cells with siRNA or a plasmid encoding green fluorescent protein were performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol.
Determination of intracellular ATP content
The luciferin-luciferase assay was used to measure intracellular ATP levels. Briefly, after rinsing three times with PBS, cells were solubilized in 200 μL (for 24-well plate) of somatic cell ATP-releasing agent (Sigma, St Louis, MO, USA). Samples were centrifuged for 5 min in a microcentrifuge. Determination of ATP levels was accomplished by combining equal volumes of supernatant with an ATP assay mix (Sigma, St Louis, MO, USA) and measuring the level of chemiluminescence. Measurements are expressed as a percent of the initial value after subtraction of background countings.
Mitochondrial respiration measurements
Mitochondria were isolated from the muscles of male Wistar rats following standard procedures [18] . To measure respiration rate, mitochondria were incubated at 37 °C in a 
Statistical analysis
Triplicates were used in each experiment and data were shown only if three independent experiments showed consistent results. All results are expressed as the mean±SEM. Statistical differences between groups were determined by using the unpaired Student's t-test. P<0.05 was considered statistically significant. P<0.05, P<0.01 vs control.
Results
ATG protects HepG2 cells from BFA-induced apoptosis
We identified ATG as a protective agent against ER stress through a cell-based assay, in which ER stress was induced by treating HepG2 cells with BFA, an ER-to-Golgi vesicle transport inhibitor. The MTT assay demonstrated that only 27% of the cells had survived at 72 h after BFA treatment. However, ATG inhibited the BFA-induced cell death in a dosedependent manner ( Figure 1A ). Meanwhile, a higher concentration of ATG (> 10 µmol/L) on its own caused a statistically significant decrease in cell number ( Figure 1A ), so we chose 5 μmol/L for further studies of its effects on reducing ER stress.
To determine whether ATG specifically affects the ER stressinduced cell death, we investigated the effects of ATG on cell death induced by non-ER stress stimuli, including protein synthesis inhibitor cycloheximide (CHX), DNA topoisomerase II inhibitor adriamycin (ADM), and the mitochondrial complex I inhibitor berberine (BBR) [18] . Our data showed that ATG had no protective effect against CHX-, ADM-, or BBR-induced cell death, which indicates that ATG may specifically inhibit ER stress-induced cell death ( Figure 1B) .
The protective effect of ATG against BFA-induced cell death was further confirmed by PI (propidium iodide) staining and PARP cleavage assay. As shown in Figure 1C , BFA increased the number of round and PI-stained cells, which were obviously inhibited by ATG. As reported, BFA induced apoptosis as indicated by poly (ADP-ribose) polymerase (PARP) cleavage. Co-treatment with ATG significantly prevented the BFA- Figure 1C and 1D ). These data demonstrate that ATG can effectively protect HepG2 cells from the ER stress inducer (BFA)-induced apoptosis.
ATG down-regulates UPR signaling pathways induced by ER stress To confirm that ATG protects cells from apoptosis by alleviating ER stress, we investigated the effects of ATG on UPR signaling pathways. Our data showed that BFA increased the We further used quantitative PCR to evaluate the effects of ATG on the expression of the downstream genes involved in the UPR, which include the activating transcription factor 4 (ATF4), the C/EBP homologous protein (CHOP), the glucose-regulated protein 94 (Grp94), and the ER degradationenhancing alpha-mannosidase-like protein 1 (EDEM). Our data showed that ATG significantly inhibited BFA-induced expression of all four genes ( Figure 2C ). In addition, we also investigated the effect of ATG on the UPR induced by tunicamycin (TM), another ER stress inducer that inhibits N-linked glycosylation in the ER. As shown in supplymentary Figure 1 , ATG significantly inhibited tunicamycin-induced splicing of XBP-1 pre-mRNA and mRNA expression of four downstream genes involved in the UPR. These results demonstrate that ATG protects cells from BFA-induced apoptosis via alleviating ER stress, and suggest that ATG may act upstream of the UPR, since all downstream signaling pathways were affected.
ATG attenuates protein translation
In mammalian cells, global translation attenuation is the first response to ER stress and is thought to be an important adaptive response that helps cells survive ER stress. Previous studies also reported that protein synthesis inhibitors such as cycloheximide [19] and salubrinal [20] displayed potential ER stress-relieving effects. Therefore, inhibition of protein syn- 
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Acta Pharmacologica Sinica npg thesis which reduces the load of substrates presented to the folding machinery in the ER lumen represents an important mechanism to alleviate ER stress [21] . To explore whether ATG affects protein synthesis, we transfected HepG2 cells with a plasmid encoding green fluorescent protein (GFP), and evaluated the effect of ATG on GFP expression by dividing the IOD (integral optical density) value of green fluorescence by the number of cells that was measured by Hoechst staining. As shown in Figure 3A , 24 h after treatment with ATG, the level of GFP protein was decreased in a dose-dependent manner. Cycloheximide (CHX) served as a positive control. However, neither artigenin nor CHX had effects on the mRNA level of GFP ( Figure 3B ). These data indicate that ATG can inhibit protein synthesis, which in turn reduces the load on the ER and thereby relieves ER stress.
To investigate how ATG regulates protein translation, we analyzed the effects of ATG on signaling proteins that are responsible for translational control, which include eIF2α, mTOR (the mammalian target of rapamycin) and p70S6K (p70 ribosomal protein S6 kinase), two components in mTOR signaling, and eEF2 (the eukaryotic translation elongation factor 2). Our data showed that ATG had no effects on the phosphorylation of eIF2α. However, it significantly inhibited the phosphorylation of mTOR and p70S6K in a dose dependent manner, and increased the phosphorylation/inactivation of eEF2 at threonine (Thr) 56 ( Figure 3C ).
We also examined the effects of ATG on these proteins in BFA-treated cells. BFA induced an increase in eIF2α phosphorylation, which was inhibited by ATG ( Figure 3D ), although ATG alone had no effect on the basal level phosphorylation of eIF2α. BFA had no effects on the phophorylation of either p70S6K or eEF2 ( Figure 3D ), suggesting that the inhibitory effect of ATG on protein translation was unaffected by BFA.
These data suggest that ATG attenuates protein synthesis likely through inhibiting mTOR-p70S6K signaling and eEF2 activity.
ATG reduces the unfolded protein response by activating AMPK It has been reported that AMPK acts upstream of mTOR signaling and eEF2 in controlling translation. AMPK modulates the activity of mTOR either by direct phosphorylation and inhibition of mTOR [22] , or by phosphorylation and activation of the tuberous sclerosis complex (TSC), an upstream regulator and inhibitor of mTOR activity [23] . The most characterized downstream effectors of mTOR are p70S6K and the eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1), through which mTOR stimulates the initiation step of translation [24] . AMPK can also activate eEF2 kinase (eEF2K) either by direct phosphorylation of eEF2K at Ser398 [25] , or by inhibition of p70S6K. which phosphorylates and inactivates eEF2K at Ser366 [26] . Activated eEF2K in turn phosphorylates and inactivates eEF2 at Thr56 [27] . We therefore investigated the effect of ATG on AMPK phosphorylation/activation. As shown in Figure 4 , ATG significantly stimulated the phosphorylation of AMPK at Thr172 of α catalytic subunit in a timeand dose-dependent manner ( Figure 4A and 4B) . ATG also increased the phosphorylation of ACC (acetyl-CoA carboxylase) at Ser79, a direct substrate of AMPK [28] , indicating an increase in AMPK activity was induced ( Figure 4B ).
To determine whether the attenuation of protein translation by ATG is mediated by AMPK activation, we employed RNA interference to knock down AMPKα1. As shown in Figure 4C , siRNA-mediated AMPKα1 down-regulation partially reversed the effect of ATG on the phosphorylation of p70S6K and eEF2. These data suggest that AMPK activation at least partially mediates the inhibitory effect of ATG on protein translation.
To further verify that the alleviation of ER stress by ATG is mediated by AMPK activation, we used a selective inhibitor of AMPK, compound C (CC), to block AMPK activity. As shown in Figure 4D and 4E, compound CC significantly reduced the effects of ATG on the BFA-induced XBP-1 splicing and mRNA expression of Grp94, suggesting that the activation of AMPK is necessary for ATG's inhibitory effect on the BFA-induced UPR. Meanwhile, CC itself had no effects on the splicing of XBP-1 pre-mRNA ( Figure 4D ). The involvement of AMPK in the ATG inhibition of ER stress was further confirmed by using a known AMPK activator AICAR. Similar to artigenin, AICAR significantly prevented BFA-induced cell death in a dose-dependent manner ( Figure 4F ).
Taken together, our observations demonstrate that ATG alleviates ER stress probably through activating AMPK, which attenuates protein translation and reduces ER load.
ATG inhibits mitochondrial respiration, leading to AMPK activation There are two main protein kinases involved in phosphorylating AMPK in vivo, LKB1 (liver kinase B1) and Ca 2+ /calmodulin-denpendent protein kinase kinase, especially the β isoform (CaMKKβ) [29] . To determine whether the two kinases are critically involved in the ATG-induced AMPK phosphorylation, we used RNA interference to down-regulate the expression of LKB1 and CaMKKβ. As shown in Figure 5 , knockdown of either LKB1 or CaMKKβ significantly reduced the phosphorylation of AMPK induced by ATG, suggesting that both kinases are involved in mediating the ATG-induced AMPK activation ( Figure 5A ).
Phosphorylation of AMPK by the two kinases is regulated by adenosine monophosphate (AMP), which allosterically activates AMPK and makes it a better substrate for the two upstream kinases and a poorer substrate for protein phosphatases [30] . The intracellular AMP level, however, is regulated by adenosine triphosphate (ATP) content. ATP depletion has been shown to increase AMP production as a consequence of the reaction catalyzed by adenylate kinase [30] . To investigate whether ATG affects ATP production, we evaluated intracellular ATP levels by a luciferase assay. As shown in Figure  5 , intracellular ATP levels were reduced by ATG in a timedependent and dose-dependent manner ( Figure 5B and 5C) .
Given the fact that mitochondria are the major ATP production organelles in eukaryotes, we investigated the effects of ATG on mitochondrial respiration in mitochondria isolated from rat muscle. Our data showed that ATG inhibited oxygen 
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Acta Pharmacologica Sinica npg consumption in a dose-dependent manner in the presence of substrates for complex I (pyruvate plus malate). In contrast, no effect of ATG on mitochondrial respiration was observed in the presence of substrate for complex II (succinate) and rotenone ( Figure 5D ). Taken together, our data demonstrate that ATG selectively inhibits mitochondrial respiration supported by substrates for complex I and decreases ATP production likely leading to AMPK phosphorylation/activation.
ATG protects INS-1 β-cells from palmitate-induced cell death
It has been reported that exposure to high concentrations of free (nonesterified) fatty acid (FFA) induces ER stress and causes β-cell apoptosis [8, 31] , which has been considered as one of the major causes of insufficient insulin production in type 2 diabetes [32, 33] . We therefore investigated the effects of ATG on palmitate-induced β-cell death. Palmitate severely decreased cell viability of INS-1 β-cells, while treatment with ATG significantly prevented cell death in a dose-dependent manner ( Figure 6A ). We then investigated whether ATG could activate AMPK in INS-1 cells. Our data showed that ATG significantly increased the phosphorylation of AMPK in the absence or presence of palmitate ( Figure 6B ). Furthermore, we examined the effects of ATG on palmitate-induced UPR in INS-1 cells. As shown in Figure 6C , 6D, and 6E, palmitate promoted the splicing of XBP-1 pre-mRNA and the mRNA expression of Grp78 and Grp94, which were significantly inhibited by ATG. These data suggest that ATG protects INS-1 cells from palmitate-induced cell death probably through alleviating ER stress and the protective effects of ATG against ER stress are not specific in HepG2 cells.
Discussion
There has been growing interest in therapeutic strategies to alleviate ER stress, since prolonged ER stress has been associated with a wide range of pathological conditions [5] . ER stress has been thought to play a central role in the pathogenesis of type 2 diabetes not only because of its role in the induction of insulin resistance but also because of its involvement in β-cell death, a common feature of type 2 diabetes [34] . Therefore, compounds that alleviate ER stress may act as therapeutic agents for the treatment of β-cell loss in type 2 diabetes. In this study, we have identified ATG, a natural product from Arctium lappa L, as a candidate for alleviating ER stress.
Firstly, we presented two lines of evidences to demonstrate that ATG was an ER stress alleviator (Figure 1, 2 , and supplementary Figure 1 ). First, ATG protected HepG2 cells from ER stress inducer BFA-induced apoptosis, but showed no protective effect against non-ER stress stimuli. Our data showed that the lowest effective dose of ATG is 2.5 µmol/L and ATG at higher dose (>10 µmol/L) displayed cytotoxicity, which might suggest a narrow therapeutic window. However, our data also showed that the protective effect of ATG at 10 µmol/L was quite marked. We therefore assume that ATG may have a wider therapeutic range in clinical settings. Second, ATG inhibited BFA-and tunicamycin-induced UPR, ie, the splicing of XBP-1 pre-mRNA, the phosphorylation of eIF2α and the expression of downstream UPR target genes, including Grp94, EDEM, ATF4, and CHOP. The UPR is involved in both survival and the apoptotic response [35] . Whether a cell survives or dies upon ER stress will depend on the balance of these opposing signals. In this case, BFA-induced ER stress caused cell apoptosis, which means that the pro-death signal overrides the pro-survival signal. Inhibition of the UPR by ATG promoted cell survival, although ATG inhibited both pro-survival and pro-death signaling downstream of the UPR.
To investigate whether ATG alleviates ER stress through attenuating protein synthesis, we analyzed the effects of ATG on the protein expression level of a transfected GFP gene. Our data demonstrated that ATG decreased the level of GFP protein without influencing its transcription ( Figure 3A and 3B) . We also examined the effects of ATG on protein degradation and autophagy. Our data showed that ATG had no effects on either protein degradation or autophagy (unpublished data). We therefore conclude that ATG reduced protein expression level by inhibiting protein translation but not transcription or degradation, by which ATG may relieve ER stress.
Unlike some of the ER stress alleviators, such as salubrinal which reduces ER load by inducing the phosphorylation of eIF2α [20] , therefore inhibiting the initiation of protein translation, ATG did not seem to affect the initiation factor eIF2α, but significantly inhibited phosphorylation of mTOR-p70S6K signaling and induced phosphorylation/inactivation of the protein translation elongation factor eEF2 ( Figure 3C and 3D) , suggesting that ATG attenuates protein synthesis by inhibiting both translation initiation and elongation.
Therefore, inhibition of protein synthesis represents an effective strategy to reduce ER stress. Once the protein synthesis is reduced, inhibition of downstream protein modification and/ or folding, as caused by BFA and/or TM, will no longer elicit an UPR. Consistent with this notion, the BFA-induced phosphorylation of eIF2α is inhibited by ATG, although ATG itself does not directly affect eIF2α phosphorylation ( Figure 3D ).
Both mTOR-p70S6K signaling and eEF2 have been reported to be regulated by AMPK [36] . We therefore investigated whether ATG activated AMPK, and if so, whether AMPK activation mediated ATG action. Our data showed that ATG obviously increased the phosphorylation/activation of AMPK. Encouragingly, knockdown of AMPKα1 by RNA interference partially reversed the effect of ATG on the phosphorylation of p70S6K and eEF2. Furthermore, an AMPK inhibitor, compound C, could block the inhibitory effect of ATG on BFAinduced XBP-1 splicing, whereas an AMPK activator, AICAR, could mimic ATG to reduce the ER stress-induced cell death. These data strongly suggest that AMPK plays a central role in mediating all of the ATG effects in alleviating ER stress. Our results, together with an earlier report [37] , also indicate that activating AMPK could be an effective strategy for ER stress reduction.
AMPK is widely recognized as a key regulator of fatty acid and glucose homeostasis [30] , and the activation of AMPK has been considered an attractive strategy for the treatment of type 2 diabetes. The most representative compounds are metformin and berberine, which exert anti-diabetic effects through activating AMPK [18, 38] . Meanwhile, they are also reported to possess protective effect against ER stress [39] [40] [41] . Given the crucial role of ER stress in the development of pancreatic β-cell loss and insulin resistance in type 2 diabetes [6] , the alleviation of ER stress by AMPK may play an important role in treating type 2 diabetes. Consistent with this notion, our data demonstrated that ATG also protected INS-1 β-cells against palmitate-induced ER stress and cell death ( Figure 6 ). In addition, activating AMPK may also represent a potential therapeutic strategy to relieve ER stress in other ER stress-related diseases, since ER stress is associated with a number of diseases.
AMPK has been reported to be activated by its two main upstream kinases, LKB1 and CaMKKβ in response to decreased intracellular levels of ATP [29] . Our data showed that AMPK phosphorylation induced by ATG was significantly inhibited by either LKB1 or CaMKKβ siRNAs, implying that both kinases are involved in ATG-induced AMPK phosphorylation ( Figure 5A ). This is consistent with a recent study that reported ATG phosphorylated AMPK in H9C2 and C2C12 cells via LKB1 and CaMKK-denpendent pathways [42] . Furthermore, we found the intracellular ATP level was significantly reduced by ATG ( Figure 5B and 5C), which might also lead to AMPK activation. Interestingly, ATG at 0.5 μmol/L and 1 μmol/L significantly increased AMPK phosphorylation but slightly reduced the intracellular ATP levels, which implies that ATG may also activate AMPK via an ATP depletionindependent manner. Taken together, our data suggest that ATG activates AMPK probably through activating LKB1 and CaMKKβ and/or decreasing the ATP level.
Since oxidative phosphorylation and glycolysis are the two main sources of ATP in eukaryotic cells, we then investigated the effects of ATG on mitochondrial respiratory function. Our data demonstrated that ATG inhibited oxygen consumption supported by substrates for complex I but not that supported by complex II substrates ( Figure 5D ), indicating that the inhibition of mitochondrial respiration by ATG was occurring either at the level of NADH production or at complex I. These results suggest that ATG decreases the intracellular level of ATP and increases the phosphorylation/activity of AMPK through inhibiting mitochondrial respiration.
In conclusion, our findings reveal the molecular mechanism by which ATG alleviates ER stress: the inhibition of mitochondrial respiration by ATG results in reduced ATP production in mitochondria. Under conditions of energy depletion, AMPK is probably activated by LKB1 and CaMKKβ, which in turn inhibits mTOR-p70S6K signaling and increases eEF2 phosphorylation/inactivation, leading to the attenuation of protein synthesis. As a result, the burden of ER stress is relieved, and cell death is prevented (Figure 7) . We also show the protective effect of ATG against palmitate-induced INS-1 β-cell death. These data suggest that ATG may represent a potential therapeutic intervention for treating ER stress-related diseases, such as β-cell loss in type 2 diabetes. 
